•
Oct 01, 2022

Sleep Number Q3 2022 Earnings Report

Net sales decreased due to semiconductor chip supply constraints, but EPS exceeded expectations.

Key Takeaways

Sleep Number reported a decrease in net sales by 16% due to semiconductor chip supply constraints and softer consumer demand. However, the diluted EPS of $0.22 was ahead of expectations. The company revised its 2022 EPS outlook to $1.50 to $2.00 per diluted share.

Third-quarter net sales declined 16% versus the prior year due to semiconductor chip supply constraints.

Third-quarter diluted EPS of $0.22 exceeded expectations.

Revised 2022 EPS outlook to a range of $1.50 to $2.00 per diluted share.

Company is pursuing actions to improve supply, margin, and demand.

Total Revenue
$541M
Previous year: $640M
-15.6%
EPS
$0.22
Previous year: $2.22
-90.1%
Gross Margin
56.1%
Previous year: 61%
-8.0%
Gross Profit
$303M
Previous year: $390M
-22.4%
Cash and Equivalents
$1.35M
Previous year: $1.83M
-26.3%
Free Cash Flow
$35.2M
Total Assets
$941M

Sleep Number

Sleep Number

Forward Guidance

The company updated its full-year 2022 diluted EPS outlook to a range of $1.50 to $2.00 per share driven by insufficient and uneven flow of chip supply and softer demand. The outlook assumes flat net sales versus the prior year for the fourth quarter. The company anticipates 2022 capital expenditures of approximately $70 million.

Positive Outlook

  • EPS outlook between $1.50 and $2.00
  • Expects flat net sales for Q4

Challenges Ahead

  • Insufficient and uneven flow of chip supply
  • Softer demand